Program

Speakers & Session Details

October 12 (Wed)

PL 1 : Continued success of Xcopri development: NDA, subsequent development and commercialization

Title

[] Plenary Lecture 1

Plenary Lecture 1

Chair

    • In-Jin Jang
    • Seoul National University Hospital
    • KOREA, REPUBLIC OF

Summary

Continued success of XCOPRI® development: NDA, subsequent development and commercialization

Jeong-Woo Cho


SK Biopharmaceuticals Co., Ltd.


KOREA, REPUBLIC OF

Bio Essay

Abstract

PS 1 Talkshow: Creating global success of drug development in extremely competitive environment

Title

[] Plenary Session1

Plenary Session1

Chair

    • Hanlim Moon
    • MediRama
    • KOREA, REPUBLIC OF

Summary

PS 1 Talkshow: Creating global success of drug development in extremely competitive environment

- -


-


KOREA, REPUBLIC OF

Bio Essay

Abstract

S1 : Patient-Centric Drug Development & S4 : Drug Delivery to the Target Tissue

Title

[] S1: Patient-Centric Drug Development

S1: Patient-Centric Drug Development

Chair

    • BG Rhee
    • GI-Innovation
    • KOREA, REPUBLIC OF
    • Yu-Kyeong Hwang
    • YUYA BIO CONSULTING
    • KOREA, REPUBLIC OF

Summary

Patient-Centric CAR-T Development

Dong-Hyuk Jeon


CUROCELL


KOREA, REPUBLIC OF

Bio Essay

Abstract

Symptom-specific control of movement disorders by CaV3.2 ASO

Daesoo Kim


KAIST


KOREA, REPUBLIC OF

Bio Essay

Abstract

Genetic Medicine with Non-viral Delivery Technology

Yoonchul Shin


GenEdit


KOREA, REPUBLIC OF

Bio Essay

Abstract

Title

[] S4: Drug Delivery to the Target Tissue

S4: Drug Delivery to the Target Tissue

Chair

    • Jinsan Yoo
    • PharmAbcine
    • KOREA, REPUBLIC OF
    • Jong-Seo Lee
    • AbClon
    • KOREA, REPUBLIC OF

Summary

Overcoming the Blood-Brain Barrier for RNA therapeutics

Mi Jung Lim


BIORCHESTRA Co., Ltd.


KOREA, REPUBLIC OF

Bio Essay

Abstract

Brain Somatic Mutations as RNA Therapeutic Targets in Neurological Disorders

Jeong-Ho Lee


SoVarGen/KAIST


KOREA, REPUBLIC OF

Bio Essay

Abstract

BBB Shuttle by Aptamer Technology

Daekyun Lee


Aptamer Sciences


KOREA, REPUBLIC OF

Bio Essay

Abstract

New era of mRNA Therapeutics

Hyun-Bae Jie


Levatio Therapeutics


UNITED STATES

Bio Essay

Abstract

S2 : Creating Comprehensive Drug Development Plan: Strategic Planning through the Product Lifecycle & S5 : Creating Comprehensive Drug Development Plan

Title

[] S2 : Creating Comprehensive Drug Development Plan: Strategic Planning through the Product Lifecycle

S2 : Creating Comprehensive Drug Development Plan: Strategic Planning through the Product Lifecycle

Chair

    • Mi-Young Bahng
    • Dong-A ST
    • KOREA, REPUBLIC OF
    • Jungshin Park
    • SK Biopharmaceuticals
    • KOREA, REPUBLIC OF

Summary

Begin with end in mind: Target product profile and clinical development plan

Nari Yun


GI Innovation


KOREA, REPUBLIC OF

Bio Essay

Abstract

Orphan Drug and Expedited Drug Development Programs in US/EU

Hye Jin Choi


IQVIA


KOREA, REPUBLIC OF

Bio Essay

Abstract

Global & Market Expansion of K-CAB

Eunji Kim


HK inno.N


KOREA, REPUBLIC OF

Bio Essay

Abstract

Title

[] S5 : Creating Comprehensive Drug Development Plan: Strategic Planning through Multifunctional Integration

S5 : Creating Comprehensive Drug Development Plan: Strategic Planning through Multifunctional Integration

Chair

    • Myunghoon Kim
    • KMD Bio
    • KOREA, REPUBLIC OF
    • Sora Lee
    • Daewon Pharm
    • KOREA, REPUBLIC OF

Summary

Marketing principles applied to clinical development

Seungwon Jeong


Hanall Bio


KOREA, REPUBLIC OF

Bio Essay

Abstract

Clinical Trial Design for Regulatory and Commercial Success

Miyoung Kim


LG Chemical Life Sciences


KOREA, REPUBLIC OF

Bio Essay

Abstract

Biostatistical Validation of Protocol for Clinical and Commercial Success

Sang Joon Lee


Celltrion


UNITED STATES

Bio Essay

Abstract

How to Incorporate Market Access Strategy to Clinical Trials

Yuri Lee


AMGEN


KOREA, REPUBLIC OF

Bio Essay

Abstract

S3 : Understanding Market and Investment Theory & S6: Practical Investment Guide based on Real Cases

Title

[] S3 : Understanding Market and Investment Theory

S3 : Understanding Market and Investment Theory

Chair

    • Myungkee Kim
    • LSK Investment
    • KOREA, REPUBLIC OF

Summary

Global/Korean Life Science Investment Market Trend

Min Sik Shin


KB Investment


KOREA, REPUBLIC OF

Bio Essay

Abstract

Selecting the Right Biotech Company to Invest

Aleum Lee


IMM Investment


KOREA, REPUBLIC OF

Bio Essay

Abstract

Opportunities Created by a Bear Market

Ted Moon


RM Global Partners


UNITED STATES

Bio Essay

Abstract

Healthcare Company IPO Trends & Technology Assessment Listing Track Strategies

Wonje Kim


Samsung Securities Co., Ltd


KOREA, REPUBLIC OF

Bio Essay

Abstract

Title

[] S6 : Practical Investment Guide based on Real Cases

S6 : Practical Investment Guide based on Real Cases

Chair

    • Minsik Park
    • STIC Ventures
    • KOREA, REPUBLIC OF

Summary

IPO by Technology Assessment Listing

Jung-Sun Yum


CHA Vaccine Institute


KOREA, REPUBLIC OF

Bio Essay

Abstract

Listing Experiences in the KONEX & KOSDAQ - Genome & Company

Youngjin Seo


Genome & Company


KOREA, REPUBLIC OF

Bio Essay

Abstract

IPO by Special Purpose Acquisition Company (SPAC)

Kisub Lee


Kainos Medicine


KOREA, REPUBLIC OF

Bio Essay

Abstract

up